PedaleoVR: Credibility, Usability and Intrinsic Motivation Study

NCT05162040 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2021-12-17

No results posted yet for this study

Summary

The objective of this research is to combine the use of inertial systems with virtual reality in pedalling exercises in a pilot study with subjects with ataxia or hemiparesis. In particular, it is intended to evaluate the validity of the system as a physical training tool for pedalling exercises aimed at providing motivational visual stimuli and biofeedback based on pedalling cadence to improve the exercise experience and promote adherence to the subject's treatment.

Primary objectives:

* To study the estimation of pedalling cadence performed by the system/platform in subjects with hemiparesis or ataxia..
* To study the usability, credibility and intrinsic motivation characteristics of the platform

Conditions

  • Ataxia, Motor
  • Hemiparesis

Interventions

DEVICE

Use of PedaleoVR

All participants must undergo an evaluation of their motor skills through the application of physical assessment metrics performed by the physician. The metrics are the Timed Up-and-Go Test (TUG) and the 6-minute walk test. Next, they must perform a pedaling exercise on a bicycle or stationary pedaling station synchronizing the physical activity with the visual feedback from the virtual reality application. Two pedalling sets of 10 minutes each are performed, with 5 minutes of rest between sets. Finally, the participant is asked to rate the usability: System Usability Rating Scale (SUS), activity credibility (Credibility and Expectancy Questionnaire, CEQ) and intrinsic motivation (Intrinsic Motivation Inventory, IMI) of the virtual reality application.

Sponsors & Collaborators

  • Centro Lescer

    collaborator UNKNOWN
  • Cajal Institute of the Spanish National Research Council

    collaborator OTHER
  • Werium Assistive Solutions

    lead INDUSTRY

Principal Investigators

  • Ana Rojo, PhD Student · Werium Assistive Solutions

Eligibility

Min Age
39 Years
Max Age
88 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2021-11-01
Completion
2021-11-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05162040 on ClinicalTrials.gov